Ripple Therapeutics Overview
- Year Founded
-
2019
- Status
-
Private
- Employees
-
41
- Latest Deal Type
-
Grant
- Latest Deal Amount
-
$595K
- Investors
-
9
Ripple Therapeutics General Information
Description
Developer of a drug delivery system designed for sustained drug delivery without the use of polymers or excipients. The company focuses on ophthalmic therapeutics and specializes in discovering and engineering drugs into controlled-release materials without the use of polymers or excipients, and its prodrug materials are readily manufactured into implantable forms like cylinders and microspheres, providing patients with better outcomes, easier management of care for physicians, and lower costs for payors.
Contact Information
Website
www.rippletherapeutics.comCorporate Office
- MaRS Center, South Tower
- 101 College Street, Suite 300
- Toronto, Ontario M5G 1L7
- Canada
Corporate Office
- MaRS Center, South Tower
- 101 College Street, Suite 300
- Toronto, Ontario M5G 1L7
- Canada
Ripple Therapeutics Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 6. Grant | 27-Apr-2022 | $595K | Completed | Clinical Trials - Phase 1 | ||
| 5. Early Stage VC (Series A) | 08-Mar-2022 | Completed | Clinical Trials - Phase 1 | |||
| 4. Accelerator/Incubator | 01-May-2020 | Completed | Startup | |||
| 3. Seed Round | 02-Jan-2020 | Completed | Clinical Trials - Phase 1 | |||
| 2. Accelerator/Incubator | Completed | Clinical Trials - Phase 1 | ||||
| 1. University Spin-Out | 01-Jan-2019 | Completed | Startup |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Ripple Therapeutics Patents
Ripple Therapeutics Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| US-20260193289-A1 | Processable statins and use for the same | Pending | 19-Dec-2024 | ||
| WO-2026132908-A1 | Processable statins and use for the same | Pending | 19-Dec-2024 | ||
| WO-2026132909-A2 | Processable statins and use for the same | Pending | 19-Dec-2024 | ||
| WO-2026132909-A3 | Steroid linked statins as implants for ophthalmic use | Pending | 19-Dec-2024 | ||
| US-20260007686-A1 | Compositions and methods for improving vision | Pending | 12-Jul-2022 | A61K31/573 |
Ripple Therapeutics Signals
Ripple Therapeutics Investors (9)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| National Research Council Canada | Government | |||
| Théa Open Innovation | Venture Capital | Minority | ||
| Ontario Bioscience Innovation Organization | Not-For-Profit Venture Capital | |||
| BDC Capital | Growth/Expansion | Minority | ||
| Covington Capital Corporation | Venture Capital | Minority |
Ripple Therapeutics FAQs
-
When was Ripple Therapeutics founded?
Ripple Therapeutics was founded in 2019.
-
Where is Ripple Therapeutics headquartered?
Ripple Therapeutics is headquartered in Toronto, Canada.
-
What is the size of Ripple Therapeutics?
Ripple Therapeutics has 41 total employees.
-
What industry is Ripple Therapeutics in?
Ripple Therapeutics’s primary industry is Drug Delivery.
-
Is Ripple Therapeutics a private or public company?
Ripple Therapeutics is a Private company.
-
What is Ripple Therapeutics’s current revenue?
The current revenue for Ripple Therapeutics is .
-
How much funding has Ripple Therapeutics raised over time?
Ripple Therapeutics has raised $23.4M.
-
Who are Ripple Therapeutics’s investors?
National Research Council Canada, Théa Open Innovation, Ontario Bioscience Innovation Organization, BDC Capital, and Covington Capital Corporation are 5 of 9 investors who have invested in Ripple Therapeutics.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process